Gatt Technologies Bv
Clinical trials sponsored by Gatt Technologies Bv, explained in plain language.
-
New patch aims to stop surgical bleeding faster
Disease control CompletedThis study tested a new medical patch called GATT-Patch against a standard patch (TachoSil) to see which works better at stopping bleeding during planned open liver surgery. It involved 132 patients who had minimal to moderate bleeding that standard techniques couldn't easily con…
Phase: NA • Sponsor: GATT Technologies BV • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New surgical patch aims to seal bleeding faster in liver operations
Disease control CompletedThis study tested a new medical patch called GATT-Patch, designed to stop bleeding during minimally invasive liver and gallbladder surgeries. It was compared directly to a commonly used product, SURGICEL® Original. The main goal was to see if the new patch could control minimal t…
Phase: NA • Sponsor: GATT Technologies BV • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC